Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
325.40
+14.70 (4.73%)
Jan 7, 2026, 10:08 AM EST - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.71 billion as of January 7, 2026. Its market cap has decreased by -4.01% in one year.
Market Cap
8.71B
Enterprise Value
8.68B
1-Year Change
-4.01%
Ranking
Category
Stock Price
$325.40
Market Cap Chart
Since January 8, 2021, Bio-Rad Laboratories's market cap has decreased from $18.53B to $8.71B, a decrease of -53.02%. That is a compound annual growth rate of -14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 8.76B | 7.43% |
| Dec 31, 2025 | 8.16B | -11.31% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 22.04% |
| Jan 8, 2021 | 18.53B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.14B |
| Johnson & Johnson | 499.54B |
| AbbVie | 405.26B |
| UnitedHealth Group | 307.73B |
| AstraZeneca | 293.89B |
| Merck & Co. | 273.30B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |